Sage Journals: Discover world-class research

Abstract

Background:

Pharmaceutical manufacturer medical information (MI) departments play an important role in providing medical information to health care professionals (HCPs) and patients. A survey was conducted to gather insights on the utility of MI services and to understand the information needs/preferences to support therapy decisions.

Methods:

Patients (n=40) and HCPs (n=192) who requested medical information in a 3-month time frame from 4 companies were surveyed (15 questions for patients; 28 questions for HCPs).

Results:

Patients contacted MI departments for information on concerns about side effects, efficacy information, access/insurance coverage, how to take the medicine, switching medicine, how the medicine works, comparison to another medicine, medical condition information, and participating in trials. Patients reported that the medical information received changed the perception toward the treatment in the following ways: learned something new about the treatment, provided more confidence to talk to an HCP, and were potentially more likely to start treatment. Health care professionals requested medical information related to dosing, safety, patient selection, and differentiating between therapeutic options. The HCPs used the medical information to take an action (eg, managing treatment for patients or deciding to prescribe a medicine), to support informing-type of activities (eg, help guide discussions with patients, plan to use information for future treatment decisions/discussion, help with insurance coverage determination, or help to enroll patients into ongoing clinical trials), and to meet an education need (eg, self-education or sharing information with practice/colleagues).

Conclusions:

These results describe patients’ and HCPs’ information needs/preferences that provide MI departments potential areas for enhancing services.

Keywords

medical information services information needs patients health care professionals

Get full access to this article

View all access options for this article.

References

Bordoloi

Gazo

Parajpe

Clausen

Fierro

. Medical information service in the age of social media and new customer channels. Therapeutic Innovation & Regulatory Science. 2011;45:811–818.

Griffin

Baumeiste

Bowers

. Review of the evolution of medical information in light of changes in the external landscape. Therapeutic Innovation & Regulatory Science. 2014;48:NP6–NP14.

Paquette-Lemieux

Hays

Gaspo

. US medical information websites benchmarking how is the industry fairing in usability [published online ahead of print July 5, 2018]? Therapeutic Innovation & Regulatory Science. doi:10.1177/2168479018786481.

Anonymous. phactMI [website]. www.phact.mi.org/. Accessed August 1, 2018.

Fung

Chang

Patel-Romero

Suchodolski

. Survey of health care practitioners’ preferences for medical information: collective insights for impacting patient care. Therapeutic Innovation & Regulatory Science. 2016;50:569–576.

Nojiri

Patel

. Call handling in the pharmaceutical industry: a benchmarking survey. Drug Inf J. 2011;45:337–343.

Guillot

Fung

. Pharmaceutical medical information contact centers: results of three benchmarking surveys. Therapeutic Innovation & Regulatory Science. 2010;44:569–579.

Black

Marsh

Ashworth

. Assessment of customer satisfaction with verbal responses provided by a pharmaceutical company’s third-party medical information call center. Drug Inf J. 2009;43:263–271.

Fung

Merriman

Cawley

. Assessing medical information needs via an Internet-based survey. Drug Inf J. 2009;43:509–518.

10.

Santhouse

Albano

. Evaluation of Wyeth Medical Communications written responses and the impact on prescribing. Drug Inf J. 2003;37:445–450.

11.

Rawn

Hoffmann-La Roche Ltd. Drug information and safety department survey of customer needs and satisfaction. Drug Inf J. 1999;33:525–539.

12.

Bauman

Bettenhausen

. Evaluation and effectiveness of a pharmaceutical-based drug information service. Drug Inf J. 1994;28:657–665.

13.

Baker

. User survey of an industry-based drug information service. Drug Inf J. 1990;24:235–243.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.21 MB

Survey of Customers Requesting Medical Information: Preferences and Information Needs of Patients and Health Care Professionals to Support Treatment Decisions

Abstract

Background:

Methods:

Results:

Conclusions:

Keywords

Get full access to this article

References

Supplementary Material